Health and Fitness Health and Fitness
Mon, October 25, 2010
[ Mon, Oct 25th 2010 ] - Market Wire
Sanofi-aventis Initiates Phase III Study with Ter .. with Interferon Beta to Further Explore Clinical
[ Mon, Oct 25th 2010 ] - Market Wire
Peoplefirst Rehabilitation Announces New Multi-State Contracts for Therapy Services
[ Mon, Oct 25th 2010 ] - Market Wire
Geron Announces Conference Call to Discuss Financial Results for the 2010 Third Quarter
[ Mon, Oct 25th 2010 ] - Market Wire
Baxter Launches GLASSIATM in the U.S.
[ Mon, Oct 25th 2010 ] - Market Wire
PPD Significantly Expands Network of Investigators in Northern India
[ Mon, Oct 25th 2010 ] - Market Wire
Vertex Pharmaceuticals Reports Third Quarter 2010 .. ights Progress in Hepatitis C and Cystic Fibrosis
[ Mon, Oct 25th 2010 ] - Market Wire
Vertex Pharmaceuticals Announces Start of a Phase .. previr in People Not Treated Previously for Hepat
[ Mon, Oct 25th 2010 ] - Market Wire
BioSante Pharmaceuticals Reports Positive LibiGel® Data Monitoring Committee Recommendation
[ Mon, Oct 25th 2010 ] - Market Wire
ARIAD Announces Proposed Public Offering of Common Stock
[ Mon, Oct 25th 2010 ] - Market Wire
Cubist Completes Offering of $450 Million of Convertible Senior Notes
[ Mon, Oct 25th 2010 ] - Market Wire
Orthovita Schedules Third Quarter 2010 Financial Results Conference Call
[ Mon, Oct 25th 2010 ] - Market Wire
Mannatech Schedules Third Quarter 2010 Earnings Release and Conference Call
[ Mon, Oct 25th 2010 ] - Market Wire
SuperGen Reports 2010 Third Quarter Financial Results
[ Mon, Oct 25th 2010 ] - Market Wire
Ligand to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2
[ Mon, Oct 25th 2010 ] - Market Wire
Quest PharmaTech Announces Treasury Issue of Common Shares
[ Mon, Oct 25th 2010 ] - Market Wire
Apricus Bio Announces Formation of Clinical Advisory Board
[ Mon, Oct 25th 2010 ] - Market Wire
Synovis Life Technologies to Present at the Singu .. l Best of the Uncovereds Conference on November 4
[ Mon, Oct 25th 2010 ] - Market Wire
Cayston® de Gilead es superior a la tobramicina .. studio comparativo de seis meses sobre la fibrosi
[ Mon, Oct 25th 2010 ] - Market Wire
ARIAD Announces Interim Results from Randomized P .. Oral Ridaforolimus in Advanced Endometrial Cancer
[ Mon, Oct 25th 2010 ] - Market Wire
Abiomed Second Quarter Fiscal 2011 Earnings and Conference Call Notification
[ Mon, Oct 25th 2010 ] - Market Wire
Orthofix International to Participate in Oppenheimer 21st Annual Healthcare Conference
[ Mon, Oct 25th 2010 ] - Market Wire
Alkermes Announces Positive Results from Phase 1 .. on with Buprenorphine for Treatment of Cocaine Ad
[ Mon, Oct 25th 2010 ] - Market Wire
Helicos BioSciences Amends Patent Infringement La .. ciences to Include Illumina and Life Technologies
[ Mon, Oct 25th 2010 ] - Market Wire
Emeritus to Acquire Rehab Therapy Services Group
[ Mon, Oct 25th 2010 ] - Market Wire
Seattle Genetics and Millennium to Highlight Bren .. t the International Symposium on Hodgkin Lymphoma
[ Mon, Oct 25th 2010 ] - Market Wire
BioCryst to Present at Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ] - Market Wire
Bestuur Alcon kiest nieuwe voorzitter
[ Mon, Oct 25th 2010 ] - Market Wire
AngioDynamics to Participate at the 21st Annual Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ] - Market Wire
Junta de Alcon elige nuevo presidente
[ Mon, Oct 25th 2010 ] - Market Wire
Il Consiglio di amministrazione di Alcon nomina il suo nuovo Presidente

Il Consiglio di amministrazione di Alcon nomina il suo nuovo Presidente


Published on 2010-10-25 03:40:46 - Market Wire
  Print publication without navigation


HUENENBERG, Svizzera--([ BUSINESS WIRE ])--Il Consiglio di amministrazione di Alcon, Inc. (NYSE:ACL) ha eletto il Dottor Daniel Vasella Presidente del Consiglio, al posto di Cary Rayment, il quale deteneva detta carica dal 3 maggio 2005. Il Dottor Vasella anche il Presidente del Consiglio di amministrazione di Novartis AG, che divenuta la™azionista di maggioranza di Alcon dopo aver acquisito il 52 per cento delle azioni di Alcon da Nestle SA il 25 agosto 2010, innalzando la propria quota di compartecipazione al 76 per cento circa.

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.

Contributing Sources